Laparoscopic Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ-Cell Tumors: Current Status

Urologic Clinics of North America

Volumn 34, Issue 2, 2007, Pages 159-169

  Hamilton, Robert J ^a   Finelli, Antonio ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE;

BLOOD VESSEL INJURY; CANCER STAGING; CARDIOTOXICITY; DISEASE ASSOCIATION; FOLLOW UP; HEARING LOSS; HOSPITAL DISCHARGE; HUMAN; KIDNEY DISEASE; LAPAROSCOPIC RETROPERITONEAL LYMPH NODE DISSECTION; LAPAROSCOPIC SURGERY; LEUKEMIA; LUNG FIBROSIS; LYMPH NODE DISSECTION; MORBIDITY; NON SEMINOMATOUS GERMINOMA; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROGNOSIS; RAYNAUD PHENOMENON; REVIEW; SIDE EFFECT; SMALL INTESTINE OBSTRUCTION; SPERMATOGENESIS;

CLINICAL TRIALS; COST-BENEFIT ANALYSIS; FEASIBILITY STUDIES; HUMANS; LAPAROSCOPY; LYMPH NODE EXCISION; MALE; MORBIDITY; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; RETROPERITONEAL SPACE; TESTICULAR NEOPLASMS;

EID: 34247850868     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ucl.2007.02.007     Document Type: Review

References (63)

1. Rukstalis D.B., and Chodak G.W. Laparoscopic retroperitoneal lymph node dissection in a patient with stage 1 testicular carcinoma. J Urol 148 6 (1992) 1907-1909 [discussion: 1909-10]
2. Bajorin D.F., Herr H., Motzer R.J., et al. Current perspectives on the role of adjunctive surgery in combined modality treatment for patients with germ cell tumors. Semin Oncol 19 2 (1992) 148-158
3. Puc H.S., Heelan R., Mazumdar M., et al. Management of residual mass in advanced seminoma: results and recommendations from the Memorial Sloan-Kettering Cancer Center. J Clin Oncol 14 2 (1996) 454-460
4. Stephenson A.J., and Sheinfeld J. The role of retroperitoneal lymph node dissection in the management of testicular cancer. Urol Oncol 22 3 (2004) 225-233 [discussion: 234-5]
5. Whitmore Jr. W.F. Surgical treatment of adult germinal testis tumors. Semin Oncol 6 1 (1979) 55-68
6. Donohue J.P., Thornhill J.A., Foster R.S., et al. Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965 to 1989): modifications of technique and impact on ejaculation. J Urol 149 2 (1993) 237-243
7. Hermans B.P., Sweeney C.J., Foster R.S., et al. Risk of systemic metastases in clinical stage I nonseminoma germ cell testis tumor managed by retroperitoneal lymph node dissection. J Urol 163 6 (2000) 1721-1724
8. Nicolai N., Miceli R., Artusi R., et al. A simple model for predicting nodal metastasis in patients with clinical stage I nonseminomatous germ cell testicular tumors undergoing retroperitoneal lymph node dissection only. J Urol 171 1 (2004) 172-176
9. Richie J.P. Clinical stage 1 testicular cancer: the role of modified retroperitoneal lymphadenectomy. J Urol 144 5 (1990) 1160-1163
10. Hilton S., Herr H.W., Teitcher J.B., et al. CT detection of retroperitoneal lymph node metastases in patients with clinical stage I testicular nonseminomatous germ cell cancer: assessment of size and distribution criteria. AJR Am J Roentgenol 169 2 (1997) 521-525
11. Fernandez E.B., Moul J.W., Foley J.P., et al. Retroperitoneal imaging with third and fourth generation computed axial tomography in clinical stage I nonseminomatous germ cell tumors. Urology 44 4 (1994) 548-552
12. Rassweiler J.J., Frede T., Lenz E., et al. Long-term experience with laparoscopic retroperitoneal lymph node dissection in the management of low-stage testis cancer. Eur Urol 37 3 (2000) 251-260
13. Winfield H.N. Laparoscopic retroperitoneal lymphadenectomy for cancer of the testis. Urol Clin North Am 25 3 (1998) 469-478
14. Janetschek G., Reissigl A., Peschel R., et al. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous testicular tumor. Urology 44 3 (1994) 382-391
15. Finelli A., Moinzadeh A., Singh D., et al. Critique of laparoscopic lymphadenectomy in genitourinary oncology. Urol Oncol 22 3 (2004) 246-254 [discussion: 254-5]
16. Rassweiler J.J., Seemann O., Frede T., et al. Retroperitoneoscopy: experience with 200 cases. J Urol 160 4 (1998) 1265-1269
17. Hara I., Kawabata G., Yamada Y., et al. Extraperitoneal laparoscopic retroperitoneal lymph node dissection in supine position after chemotherapy for advanced testicular carcinoma. Int J Urol 11 10 (2004) 934-939
18. LeBlanc E., Caty A., Dargent D., et al. Extraperitoneal laparoscopic para-aortic lymph node dissection for early stage nonseminomatous germ cell tumors of the testis with introduction of a nerve sparing technique: description and results. J Urol 165 1 (2001) 89-92
19. Hsu T.H., Su L.M., and Ong A. Anterior extraperitoneal approach to laparoscopic retroperitoneal lymph node dissection: a novel technique. J Urol 169 1 (2003) 258-260
20. Weissbach L., and Boedefeld E.A. Localization of solitary and multiple metastases in stage II nonseminomatous testis tumor as basis for a modified staging lymph node dissection in stage I. J Urol 138 1 (1987) 77-82
21. Satoh M., Ito A., Kaiho Y., et al. Intraoperative, radio-guided sentinel lymph node mapping in laparoscopic lymph node dissection for Stage I testicular carcinoma. Cancer 103 10 (2005) 2067-2072
22. Kim K., Schwaitzberg S., and Onel E. An infrared ureteral stent to aid in laparoscopic retroperitoneal lymph node dissection. J Urol 166 5 (2001) 1815-1816
23. Tobias-Machado M., Zambon J.P., Ferreira A.D., et al. Retroperitoneal lymphadenectomy by videolaparoscopic transperitoneal approach in patients with non-seminomatous testicular tumor. Int Braz J Urol 30 5 (2004) 389-396 [discussion: 396-7]
24. Corvin S., Sturm W., Schlatter E., et al. Laparoscopic retroperitoneal lymph-node dissection with the waterjet is technically feasible and safe in testis-cancer patient. J Endourol 19 7 (2005) 823-826
25. Davol P., Sumfest J., and Rukstalis D. Robotic-assisted laparoscopic retroperitoneal lymph node dissection. Urology 67 1 (2006) 199
26. Kaiho Y., Nakagawa H., Ito A., et al. Ipsilateral seminal emission generated by electrostimulation of the lumbar sympathetic nerve during nerve sparing laparoscopic retroperitoneal lymph node dissection for testicular cancer. J Urol 172 3 (2004) 928-931
27. Kaiho Y., Nakagawa H., Takeuchi A., et al. Electrostimulation of sympathetic nerve fibers during nerve-sparing laparoscopic retroperitoneal lymph node dissection in testicular tumor. Int J Urol 10 5 (2003) 284-286
28. Castillo O.A., Urena R.D., Pinto I.F., et al. Laparoscopic retroperitoneal lymph node dissection for stage I and II NSGCT: 10 years' experience. [abstract #933]. J Urol 171 Suppl (2004) 247-248
29. Bhayani S.B., Ong A., Oh W.K., et al. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular cancer: a long-term update. Urology 62 2 (2003) 324-327
30. Albqami N., and Janetschek G. Laparoscopic retroperitoneal lymph-node dissection in the management of clinical stage I and II testicular cancer. J Endourol 19 6 (2005) 683-692 [discussion: 692]
31. Albers P., Siener R., Kliesch S., et al. Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group Trial. J Clin Oncol 21 8 (2003) 1505-1512
32. Rabbani F., Sheinfeld J., Farivar-Mohseni H., et al. Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: pattern and prognostic factors for relapse. J Clin Oncol 19 7 (2001) 2020-2025
33. Richie J.P., and Kantoff P.W. Is adjuvant chemotherapy necessary for patients with stage B1 testicular cancer?. J Clin Oncol 9 8 (1991) 1393-1396
34. Pizzocaro G., and Monfardini S. No adjuvant chemotherapy in selected patients with pathologic stage II nonseminomatous germ cell tumors of the testis. J Urol 131 4 (1984) 677-680
35. Donohue J.P., Thornhill J.A., Foster R.S., et al. The role of retroperitoneal lymphadenectomy in clinical stage B testis cancer: the Indiana University experience (1965 to 1989). J Urol 153 1 (1995) 85-89
36. Donohue J.P., Leviovitch I., Foster R.S., et al. Integration of surgery and systemic therapy: results and principles of integration. Semin Urol Oncol 16 2 (1998) 65-71
37. McKiernan J.M., Motzer R.J., Bajorin D.F., et al. Reoperative retroperitoneal surgery for nonseminomatous germ cell tumor: clinical presentation, patterns of recurrence, and outcome. Urology 62 4 (2003) 732-736
38. Baniel J., Foster R.S., Einhorn L.H., et al. Late relapse of clinical stage I testicular cancer. J Urol 154 4 (1995) 1370-1372
39. Lima G.C., Nielson M.E., Porter J.R., et al. The oncological efficacy of laparoscopic retroperitoneal lymph node dissection in the treatment of clinical stage I nonseminomatous germ cell testis cancer. [abstract #587]. J Urol 175 4 Suppl (2006) 190
40. Romero F.R., Wagner A., Brito F.A., et al. Refining the laparoscopic retroperitoneal lymph node dissection for testicular cancer. Int Braz J Urol 32 2 (2006) 196-201
41. Holtl L., Peschel R., Knapp R., et al. Primary lymphatic metastatic spread in testicular cancer occurs ventral to the lumbar vessels. Urology 59 1 (2002) 114-118
42. Steiner H., Peschel R., Janetschek G., et al. Long-term results of laparoscopic retroperitoneal lymph node dissection: a single-center 10-year experience. Urology 63 3 (2004) 550-555
43. Giusti G., Beltrami P., Tallarigo C., et al. Unilateral laparoscopic retroperitoneal lymphadenectomy for clinical stage I nonseminomatous testicular cancer. J Endourol 12 6 (1998) 561-566
44. Carver B.S., and Sheinfeld J. The current status of laparoscopic retroperitoneal lymph node dissection for non-seminomatous germ-cell tumors. Nat Clin Pract Urol 2 7 (2005) 330-335
45. Porter JR, Lange PH. Laparoscopic retroperitoneal lymph node dissection for stage I NSGCT [abstract # 302]. Presented at the American Urological Association National Meeting, Chicago, IL; April 27, 2003.
46. Heidenreich A., Albers P., Hartmann M., et al. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group. J Urol 169 5 (2003) 1710-1714
47. Janetschek G., Hobisch A., Holtl L., et al. Retroperitoneal lymphadenectomy for clinical stage I nonseminomatous testicular tumor: laparoscopy versus open surgery and impact of learning curve. J Urol 156 1 (1996) 89-93 [discussion: 94]
48. Baniel J., Foster R.S., Rowland R.G., et al. Complications of primary retroperitoneal lymph node dissection. J Urol 152 2 Pt 1 (1994) 424-427
49. Beck S.D., and Foster R.S. Long-term outcome of retroperitoneal lymph node dissection in the management of testis cancer. World J Urol 24 3 (2006) 267-272
50. Jewett M.A., Kong Y.S., Goldberg S.D., et al. Retroperitoneal lymphadenectomy for testis tumor with nerve sparing for ejaculation. J Urol 139 6 (1988) 1220-1224
51. McLeod D.G., Weiss R.B., Stablein D.M., et al. Staging relationships and outcome in early stage testicular cancer: a report from the Testicular Cancer Intergroup Study. J Urol 145 6 (1991) 1178-1183 [discussion: 1182-3]
52. Huddart R.A., Norman A., Shahidi M., et al. Cardiovascular disease as a long-term complication of treatment for testicular cancer. J Clin Oncol 21 8 (2003) 1513-1523
53. Bajorin D.F., Motzer R.J., Rodriguez E., et al. Acute nonlymphocytic leukemia in germ cell tumor patients treated with etoposide-containing chemotherapy. J Natl Cancer Inst 85 1 (1993) 60-62
54. Kawai K., and Akaza H. Bleomycin-induced pulmonary toxicity in chemotherapy for testicular cancer. Expert Opin Drug Saf 2 6 (2003) 587-596
55. Brennemann W., Stoffel-Wagner B., Helmers A., et al. Gonadal function of patients treated with cisplatin based chemotherapy for germ cell cancer. J Urol 158 3 Pt 1 (1997) 844-850
56. Vogelzang N.J., Bosl G.J., Johnson K., et al. Raynaud's phenomenon: a common toxicity after combination chemotherapy for testicular cancer. Ann Intern Med 95 3 (1981) 288-292
57. Williams S.D., Birch R., Einhorn L.H., et al. Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med 316 23 (1987) 1435-1440
58. Bosl G.J., and Motzer R.J. Testicular germ-cell cancer. N Engl J Med 337 4 (1997) 242-253
59. Rassweiler J.J., Seemann O., Henkel T.O., et al. Laparoscopic retroperitoneal lymph node dissection for nonseminomatous germ cell tumors: indications and limitations. J Urol 156 3 (1996) 1108-1113
60. Palese M.A., Su L.M., and Kavoussi L.R. Laparoscopic retroperitoneal lymph node dissection after chemotherapy. Urology 60 1 (2002) 130-134
61. Baniel J., Foster R.S., Rowland R.G., et al. Complications of post-chemotherapy retroperitoneal lymph node dissection. J Urol 153 3 Pt 2 (1995) 976-980
62. Ogan K., Lotan Y., Koeneman K., et al. Laparoscopic versus open retroperitoneal lymph node dissection: a cost analysis. J Urol 168 5 (2002) 1945-1949 [discussion: 1949]
63. Link R.E., Allaf M.E., Pili R., et al. Modeling the cost of management options for stage I nonseminomatous germ cell tumors: a decision tree analysis. J Clin Oncol 23 24 (2005) 5762-5773